Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 30
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 1451 | KONINKLIJKE KPN | 10 | 00% | 0 | 10 | 2022–2026 |
| 1452 | LEGRAND FRANCE | 10 | 220% | 0 | 8 | 2020–2026 |
| 1453 | LEONARDO | 10 | 00% | 0 | 10 | 2022–2026 |
| 1454 | LESAFFRE ET COMPAGNIE | 10 | 110% | 0 | 9 | 2020–2026 |
| 1455 | LIGHTSPEED PHOTONICS | 10 | 660% | 0 | 4 | 2020–2024 |
| 1456 | LONATI | 10 | 110% | 0 | 9 | 2022–2026 |
| 1457 | MAGENTA MEDICAL | 10 | 00% | 0 | 10 | 2022–2025 |
| 1458 | MALTA | 10 | 00% | 8 | 2 | 2023–2023 |
| 1459 | MCNEIL | 10 | 110% | 0 | 9 | 2022–2022 |
| 1460 | MIANYANG HKC OPTOELECTRONICS TECHNOLOGY | 10 | 330% | 0 | 7 | 2022–2024 |
| 1461 | MIBA GLEITLAGER AUSTRIA | 10 | 110% | 4 | 5 | 2022–2025 |
| 1462 | MODINE MANUFACTURING | 10 | 00% | 0 | 10 | 2023–2025 |
| 1463 | MORPHOTONICS HOLDING | 10 | 00% | 1 | 9 | 2022–2025 |
| 1464 | NAGRAVISION | 10 | 330% | 0 | 7 | 2021–2026 |
| 1465 | NEXEON | 10 | 00% | 0 | 10 | 2024–2026 |
| 1466 | NICOVENTURES TRADING | 10 | 00% | 1 | 9 | 2023–2024 |
| 1467 | NISHIKAWA RUBBER | 10 | 00% | 0 | 10 | 2024–2026 |
| 1468 | NORDEX BLADE TECHNOLOGY CENTRE APS | 10 | 00% | 0 | 10 | 2022–2025 |
| 1469 | NORDIC SEMICONDUCTOR ASA | 10 | 00% | 0 | 10 | 2022–2022 |
| 1470 | NOVOCURE | 10 | 110% | 2 | 7 | 2022–2025 |
| 1471 | NXERA PHARMA UK | 10 | 110% | 0 | 9 | 2022–2025 |
| 1472 | OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOST YU OBEDINENNAYA KOMPANIYA RUSAL INZHENERNO TEKHNOLOGICHESKIY TSENTR | 10 | 110% | 0 | 9 | 2022–2026 |
| 1473 | OLON | 10 | 220% | 1 | 7 | 2022–2025 |
| 1474 | OSAKA SODA | 10 | 220% | 1 | 7 | 2022–2025 |
| 1475 | PHILLIPS MEDISIZE A S | 10 | 110% | 0 | 9 | 2022–2025 |
| 1476 | PI ADVANCED MATERIALS | 10 | 00% | 0 | 10 | 2024–2025 |
| 1477 | PRECISION NEUROSCIENCE | 10 | 00% | 0 | 10 | 2024–2025 |
| 1478 | PROLOGIUM TECHNOLOGY | 10 | 660% | 1 | 3 | 2022–2025 |
| 1479 | PROVE IDENTITY | 10 | 00% | 1 | 9 | 2023–2025 |
| 1480 | PUBLICHNOE AKTSIONERNOE OBSHCHESTVO NOVATEK | 10 | 00% | 0 | 10 | 2024–2025 |
| 1481 | PUNCH POWERTRAIN | 10 | 00% | 1 | 9 | 2022–2024 |
| 1482 | RAMPART COMMUNICATIONS | 10 | 330% | 1 | 6 | 2021–2025 |
| 1483 | RANPAK | 10 | 220% | 0 | 8 | 2021–2026 |
| 1484 | REDX PHARMA | 10 | 00% | 0 | 10 | 2023–2025 |
| 1485 | REMEGEN | 10 | 110% | 0 | 9 | 2021–2025 |
| 1486 | REPSOL | 10 | 00% | 0 | 10 | 2023–2026 |
| 1487 | S P M INSTRUMENT | 10 | 00% | 0 | 10 | 2022–2026 |
| 1488 | SAVANT SYSTEMS | 10 | 550% | 0 | 5 | 2021–2025 |
| 1489 | SCHUNK TRANSIT SYSTEMS | 10 | 00% | 1 | 9 | 2022–2025 |
| 1490 | SCIENTIFIC DESIGN | 10 | 00% | 0 | 10 | 2023–2026 |
| 1491 | SGL CARBON SE | 10 | 220% | 1 | 7 | 2022–2025 |
| 1492 | SINOCELLTECH | 10 | 110% | 0 | 9 | 2021–2023 |
| 1493 | SOMALOGIC OPERATING | 10 | 00% | 1 | 9 | 2022–2023 |
| 1494 | SORTERA TECHNOLOGIES | 10 | 00% | 0 | 10 | 2023–2025 |
| 1495 | SYENSQO SPECIALTY POLYMERS ITALY | 10 | 00% | 0 | 10 | 2025–2026 |
| 1496 | TAIHO PHARMACEUTICAL | 10 | 220% | 2 | 6 | 2022–2026 |
| 1497 | TAIKISHA | 10 | 00% | 0 | 10 | 2023–2025 |
| 1498 | TAKASAGO INTERNATIONAL | 10 | 110% | 0 | 9 | 2022–2026 |
| 1499 | TE CONNECTIVITY ITALIA DISTRIBUTION S R L | 10 | 330% | 0 | 7 | 2022–2025 |
| 1500 | TEIJIN | 10 | 220% | 1 | 7 | 2022–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →